塩野義製薬の株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/05/29 | 6,076 | 6,361 | 6,040 | 6,361 | +285 | +4.7% | 3,422,300 |
2020/05/28 | 6,000 | 6,125 | 5,962 | 6,076 | +31 | +0.5% | 1,914,600 |
2020/05/27 | 5,959 | 6,075 | 5,928 | 6,045 | +154 | +2.6% | 1,313,500 |
2020/05/26 | 5,887 | 5,926 | 5,836 | 5,891 | +48 | +0.8% | 735,700 |
2020/05/25 | 5,844 | 5,898 | 5,786 | 5,843 | +94 | +1.6% | 712,800 |
2020/05/22 | 5,730 | 5,758 | 5,680 | 5,749 | +41 | +0.7% | 726,400 |
2020/05/21 | 5,755 | 5,799 | 5,691 | 5,708 | -95 | -1.6% | 1,037,700 |
2020/05/20 | 5,698 | 5,844 | 5,663 | 5,803 | +60 | +1% | 956,200 |
2020/05/19 | 5,798 | 5,837 | 5,741 | 5,743 | +120 | +2.1% | 1,632,000 |
2020/05/18 | 5,647 | 5,736 | 5,615 | 5,623 | -91 | -1.6% | 1,274,500 |
2020/05/15 | 5,790 | 5,826 | 5,648 | 5,714 | -108 | -1.9% | 1,518,000 |
2020/05/14 | 5,942 | 5,967 | 5,813 | 5,822 | -269 | -4.4% | 1,883,700 |
2020/05/13 | 5,698 | 6,107 | 5,668 | 6,091 | +584 | +10.6% | 3,472,300 |
2020/05/12 | 5,755 | 5,766 | 5,422 | 5,507 | -129 | -2.3% | 2,794,500 |
2020/05/11 | 5,960 | 6,008 | 5,636 | 5,636 | -324 | -5.4% | 1,679,000 |
2020/05/08 | 5,972 | 6,001 | 5,882 | 5,960 | +133 | +2.3% | 1,351,200 |
2020/05/07 | 5,712 | 5,877 | 5,700 | 5,827 | +56 | +1% | 1,025,600 |
2020/05/01 | 5,903 | 5,915 | 5,754 | 5,771 | -158 | -2.7% | 1,212,400 |
2020/04/30 | 6,068 | 6,097 | 5,909 | 5,929 | -72 | -1.2% | 1,853,800 |
2020/04/28 | 6,079 | 6,122 | 5,892 | 6,001 | +211 | +3.6% | 2,797,400 |
2020/04/27 | 5,651 | 5,810 | 5,635 | 5,790 | +186 | +3.3% | 984,400 |
2020/04/24 | 5,606 | 5,638 | 5,590 | 5,604 | +8 | +0.1% | 980,100 |
2020/04/23 | 5,510 | 5,596 | 5,485 | 5,596 | +67 | +1.2% | 798,000 |
2020/04/22 | 5,499 | 5,529 | 5,379 | 5,529 | +101 | +1.9% | 1,109,000 |
2020/04/21 | 5,525 | 5,541 | 5,408 | 5,428 | -72 | -1.3% | 920,600 |
2020/04/20 | 5,574 | 5,604 | 5,481 | 5,500 | -117 | -2.1% | 1,172,100 |
2020/04/17 | 5,644 | 5,662 | 5,556 | 5,617 | +95 | +1.7% | 1,056,000 |
2020/04/16 | 5,550 | 5,604 | 5,514 | 5,522 | -55 | -1% | 1,179,700 |
2020/04/15 | 5,401 | 5,577 | 5,386 | 5,577 | +120 | +2.2% | 1,781,600 |
2020/04/14 | 5,469 | 5,499 | 5,414 | 5,457 | +3 | +0.1% | 1,162,700 |
2020/04/13 | 5,465 | 5,544 | 5,437 | 5,454 | -66 | -1.2% | 496,500 |
2020/04/10 | 5,554 | 5,554 | 5,438 | 5,520 | +29 | +0.5% | 786,900 |
2020/04/09 | 5,578 | 5,590 | 5,423 | 5,491 | -36 | -0.7% | 622,400 |
2020/04/08 | 5,454 | 5,572 | 5,390 | 5,527 | +134 | +2.5% | 1,171,800 |
2020/04/07 | 5,387 | 5,461 | 5,297 | 5,393 | +15 | +0.3% | 1,049,300 |
2020/04/06 | 5,285 | 5,398 | 5,205 | 5,378 | +218 | +4.2% | 1,214,400 |
2020/04/03 | 5,096 | 5,238 | 5,073 | 5,160 | +126 | +2.5% | 1,340,500 |
2020/04/02 | 5,010 | 5,200 | 5,001 | 5,034 | -45 | -0.9% | 1,339,600 |
2020/04/01 | 5,217 | 5,270 | 5,010 | 5,079 | -238 | -4.5% | 1,245,000 |
2020/03/31 | 5,450 | 5,478 | 5,310 | 5,317 | -109 | -2% | 1,955,000 |
2020/03/30 | 5,379 | 5,492 | 5,161 | 5,426 | +150 | +2.8% | 1,909,700 |
2020/03/27 | 5,054 | 5,276 | 4,985 | 5,276 | +362 | +7.4% | 1,904,800 |
2020/03/26 | 5,000 | 5,035 | 4,833 | 4,914 | -123 | -2.4% | 1,118,300 |
2020/03/25 | 5,140 | 5,189 | 4,820 | 5,037 | +299 | +6.3% | 1,968,200 |
2020/03/24 | 4,887 | 4,981 | 4,581 | 4,738 | -9 | -0.2% | 2,979,900 |
2020/03/23 | 4,409 | 4,800 | 4,388 | 4,747 | +261 | +5.8% | 2,976,600 |
2020/03/19 | 4,600 | 4,694 | 4,379 | 4,486 | +85 | +1.9% | 4,390,100 |
2020/03/18 | 4,738 | 4,744 | 4,389 | 4,401 | -274 | -5.9% | 2,722,400 |
2020/03/17 | 4,610 | 4,888 | 4,487 | 4,675 | +35 | +0.8% | 2,521,100 |
2020/03/16 | 4,792 | 4,878 | 4,617 | 4,640 | -130 | -2.7% | 1,563,500 |
1101~
1150
件表示中 / 3586件
類似銘柄と比較する
現在ご覧いただいている「塩野義」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
塩野義 | 209,400円 | +5.7% | +3.9% | 2.74% | 10.42倍 | 1.38倍 |
|
抗HIV薬が大型製品に。感染症、疼痛・中枢神経領域に強み。米国に積極展開。欧州、アジア開拓 |
大塚HD | 891,000円 | +14.4% | +120.8% | 1.35% | 20.00倍 | 1.83倍 |
|
国内製薬大手で抗精神病薬が主力。ポカリスエットなど機能性食品も拡大。世界90カ所に工場 |
アステラス薬 | 156,200円 | +12.2% | +180.3% | 4.74% | 55.93倍 | 1.83倍 |
|
医薬品国内2位。開発技術起点の研究開発体制。前立腺がん薬が柱。遺伝子・細胞治療技術育成 |
エーザイ | 465,000円 | +1.7% | -2.9% | 3.44% | 30.51倍 | 1.60倍 |
|
神経系、がん領域に強み。認知症薬は米バイオジェンと、抗がん薬では米メルクと国際協業推進 |
協和キリン | 252,300円 | +11.3% | -5.4% | 2.30% | 19.42倍 | 1.53倍 |
|
キリン傘下。医薬品、バイオが主力。独自の抗体高活性化技術に強み。富士フイルムと提携 |
市場注目の銘柄
チャート関連のコラム